Filing Error Slices Nearly Two Years Off Roche’s UK Lucentis Protection
Firms Warned To Take Care When Paying SPC Fees
A ruling by the High Court should act as a warning to companies applying for supplementary protection certificates in the UK that they must make sure that the fees are paid for the full duration of the SPC, otherwise they could get a nasty surprise when it expires earlier than expected.
You may also be interested in...
Samsung Bioepis and Biogen have agreed a marketing deal for ‘next generation’ biosimilars aflibercept and ranibizumab in the US, Canada, Europe, Japan and Australia, as well as providing an option for Biogen to extend its existing deal to market anti-TNF biosimilars adalimumab, etanercept and infliximab in Europe and adding a further option for rights to sell these three biosimilars in China.
The US company is bringing extra supplies of lopinavir/ritonavir into France but stresses that the combination treatment is not authorized for treating patients with the coronavirus.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.